B Pasche

Author PubWeight™ 23.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001 6.36
2 The platelet function defect of cardiopulmonary bypass. Blood 1993 2.63
3 Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer 2011 1.17
4 Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. Br J Cancer 2011 1.10
5 Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol 2001 1.10
6 Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am J Hum Genet 1999 1.07
7 The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol 2009 1.01
8 Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2007 0.88
9 An evaluation of the safety of low energy emission therapy. Compr Ther 1993 0.86
10 Sleep inducing effect of low energy emission therapy. Bioelectromagnetics 1994 0.86
11 Electroencephalographic changes following low energy emission therapy. Ann Biomed Eng 1996 0.85
12 Impairment of gastric acid secretion and increase of embryonic lethality in Foxq1-deficient mice. Cytogenet Genome Res 2008 0.83
13 TGFBR1*6A is not associated with prostate cancer in men of European ancestry. Prostate Cancer Prostatic Dis 2005 0.82
14 Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition. Thromb Haemost 1987 0.79
15 Platelets and plasminogen activation. Thromb Haemost 1995 0.78
16 Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2012 0.78
17 Bright light and LEET effects on circadian rhythms, sleep and cognitive performance. Stress Med 1997 0.78
18 Thrombin inactivation on surfaces with covalently bonded heparin. Thromb Res 1986 0.76
19 Influence of high and low wall shear rates on the inhibition of factor Xa and thrombin at surfaces coated with immobilized heparin. Artif Organs 1989 0.75
20 The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems. Thromb Haemost 1990 0.75
21 Phase II study of intrabuccally-administered amplitude-modulated electromagnetic fields in patients with advanced hepatocellular carcinoma. J Clin Oncol 2009 0.75